Connection

Co-Authors

This is a "connection" page, showing publications co-authored by David Andrews and Lawrence Kenyon.
Connection Strength

0.817
  1. Andrews DW, Judy KD, Scott CB, Garcia S, Harshyne LA, Kenyon L, Talekar K, Flanders A, Atsina KB, Kim L, Martinez N, Shi W, Werner-Wasik M, Liu H, Prosniak M, Curtis M, Kean R, Ye DY, Bongiorno E, Sauma S, Exley MA, Pigott K, Hooper DC. Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma. Clin Cancer Res. 2021 Apr 01; 27(7):1912-1922.
    View in: PubMed
    Score: 0.237
  2. Wernicke AG, Dicker AP, Whiton M, Ivanidze J, Hyslop T, Hammond EH, Perry A, Andrews DW, Kenyon L. Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma. Radiat Oncol. 2010; 5:46.
    View in: PubMed
    Score: 0.113
  3. Moulding HD, Friedman DP, Curtis M, Kenyon L, Flanders AE, Paek SH, Andrews DW. Revisiting anaplastic astrocytomas I: an expansive growth pattern is associated with a better prognosis. J Magn Reson Imaging. 2008 Dec; 28(6):1311-21.
    View in: PubMed
    Score: 0.102
  4. Tang J, Flomenberg P, Harshyne L, Kenyon L, Andrews DW. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells. Clin Cancer Res. 2005 Jul 15; 11(14):5292-9.
    View in: PubMed
    Score: 0.081
  5. Behling E, Birbe R, Veznadaroglu E, Andrews DW, Flanders A, Kenyon LC. Gliosarcoma arising from an anaplastic ependymoma: a case report of a rare entity. Hum Pathol. 2004 Apr; 35(4):512-6.
    View in: PubMed
    Score: 0.074
  6. Prosniak M, Harshyne LA, Gorky J, Curtis MT, Kenyon LC, Schwaber JS, Lebrun A, Kean RB, Andrews DW, Hooper DC. Systemic Immune Bias Delineates Malignant Astrocytoma Survival Cohorts. J Immunol. 2021 Apr 01; 206(7):1483-1492.
    View in: PubMed
    Score: 0.060
  7. Harshyne LA, Nasca BJ, Kenyon LC, Andrews DW, Hooper DC. Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients. Neuro Oncol. 2016 Feb; 18(2):206-15.
    View in: PubMed
    Score: 0.040
  8. Harshyne LA, Hooper KM, Andrews EG, Nasca BJ, Kenyon LC, Andrews DW, Hooper DC. Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm. Cancer Immunol Immunother. 2015 Mar; 64(3):299-309.
    View in: PubMed
    Score: 0.039
  9. Prosniak M, Harshyne LA, Andrews DW, Kenyon LC, Bedelbaeva K, Apanasovich TV, Heber-Katz E, Curtis MT, Cotzia P, Hooper DC. Glioma grade is associated with the accumulation and activity of cells bearing m2 monocyte markers. Clin Cancer Res. 2013 Jul 15; 19(14):3776-86.
    View in: PubMed
    Score: 0.035
  10. Bloomer CW, Kenyon L, Hammond E, Hyslop T, Andrews DW, Curran WJ, Dicker AP. Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) expression in human pituitary macroadenomas. Am J Clin Oncol. 2003 Aug; 26(4):S75-80.
    View in: PubMed
    Score: 0.018
  11. Lin CC, Kenyon L, Hyslop T, Hammond E, Andrews DW, Curran WJ, Dicker AP. Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade. Am J Clin Oncol. 2003 Aug; 26(4):S98-102.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.